Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16708439 | 0.90 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL16708444 | 0.89 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL17717372 | 0.87 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL16708446 | 0.87 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL16708438 | 0.87 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL677131 | 0.83 | SCN9A (0.35) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL16708445 | 0.83 | NAAA (0.30) | ALDH1A1MEN1KMT2A | |
| SCHEMBL822920 | 0.81 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL12409923 | 0.81 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2AL3MBTL1THRB | |
| SCHEMBL75666 | 0.80 | GAA (0.36) | ALDH1A1MEN1KMT2ATHRBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9376621-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9376621-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20150129801-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
| US-20150129801-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150129801-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | BACE1, DRD1, CHRM1 | ALDH1A1 934/4885MEN1 1095/4885KMT2A 3283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.